| Fosfomycin Synergy In Vitro with Amoxicillin, Daptomycin, and Linezolid against Vancomycin-Resistant Enterococcus faecium from Renal Transplant Patients with … JL Descourouez, MR Jorgenson, JE Wergin, WE Rose Antimicrobial agents and chemotherapy 57 (3), 1518-1520, 2013 | 73 | 2013 |
| Vancomycin Prophylaxis for Prevention of Clostridium difficile Infection Recurrence in Renal Transplant Patients LE Splinter, L Kerstenetzky, MR Jorgenson, JL Descourouez, ... Annals of Pharmacotherapy 52 (2), 113-119, 2018 | 34 | 2018 |
| Ganciclovir‐resistant cytomegalovirus infection in abdominal solid organ transplant recipients: case series and review of the literature KE Rolling, MR Jorgenson, JL Descourouez, DA Mandelbrot, RR Redfield, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 37 (10 …, 2017 | 29 | 2017 |
| Risk of opportunistic infection in kidney transplant recipients with cytomegalovirus infection and associated outcomes MR Jorgenson, JL Descourouez, B Cardinale, B Lyu, BC Astor, N Garg, ... Transplant Infectious Disease 21 (3), e13080, 2019 | 22 | 2019 |
| The development and implementation of stewardship initiatives to optimize the prevention and treatment of cytomegalovirus infection in solid-organ transplant recipients MR Jorgenson, JL Descourouez, LT Schulz, KA Goldrosen, JP Rice, ... Infection Control & Hospital Epidemiology 41 (9), 1068-1074, 2020 | 21 | 2020 |
| Pharmacists’ guide to the management of organ donors after brain death C Korte, JL Garber, JL Descourouez, KR Richards, K Hardinger American Journal of Health-System Pharmacy 73 (22), 1829-1839, 2016 | 20 | 2016 |
| Cytomegalovirus antiviral stewardship in solid organ transplant recipients: a new gold standard MR Jorgenson, JL Descourouez, H Kleiboeker, K Goldrosen, L Schulz, ... Transplant Infectious Disease 24 (5), e13864, 2022 | 18 | 2022 |
| Efficacy and safety of probiotics and synbiotics in liver transplantation MR Jorgenson, JL Descourouez, M Siodlak, S Tjugum, JP Rice, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 38 (7 …, 2018 | 18 | 2018 |
| The risk of cytomegalovirus infection after treatment of acute rejection in renal transplant recipients MR Jorgenson, JL Descourouez, B Lyu, BC Astor, N Garg, JA Smith, ... Clinical transplantation 33 (8), e13636, 2019 | 16 | 2019 |
| Pneumocystis jiroveci pneumonia in kidney and simultaneous pancreas kidney transplant recipients in the present era of routine post-transplant prophylaxis: risk … N Garg, M Jorgenson, J Descourouez, CM Saddler, S Parajuli, BC Astor, ... BMC nephrology 19, 1-7, 2018 | 16 | 2018 |
| Clinically significant drug interaction between clotrimazole and tacrolimus in pancreas transplant recipients and associated risk of allograft rejection CW Viesselmann, JL Descourouez, MR Jorgenson, NA Radke, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 36 (3 …, 2016 | 15 | 2016 |
| Assessing pharmacologic and nonpharmacologic risks in candidates for kidney transplantation AQ Maldonado, EM Tichy, CC Rogers, M Campara, C Ensor, ... American Journal of Health-System Pharmacy 72 (10), 781-793, 2015 | 15 | 2015 |
| The addition of adjunctive letermovir to valganciclovir for refractory cytomegalovirus viremia in kidney transplant recipients MR Jorgenson, JL Descourouez, N Garg, S Parajuli, DA Mandelbrot, ... Transplant Infectious Disease 23 (4), e13693, 2021 | 13 | 2021 |
| Cytomegalovirus antiviral stewardship in the COVID‐19 era: increasing complexity of prophylaxis and treatment and potential mitigation strategies MR Jorgenson, JL Descourouez, C Wong, JR Strayer, S Parajuli, JP Rice, ... Transplant Infectious Disease 23 (4), e13586, 2021 | 10 | 2021 |
| Management of BK viremia is associated with a lower risk of subsequent cytomegalovirus infection in kidney transplant recipients MR Jorgenson, JL Descourouez, B Lyu, BC Astor, CM Saddler, ... Clinical Transplantation 34 (3), e13798, 2020 | 10 | 2020 |
| A targeted fungal prophylaxis protocol with static dosed fluconazole significantly reduces invasive fungal infection after liver transplantation MR Jorgenson, JL Descourouez, NA Marka, GE Leverson, JA Smith, ... Transplant Infectious Disease 21 (5), e13156, 2019 | 10 | 2019 |
| The clinical conundrum of cannabis: current practices and recommendations for transplant clinicians: an opinion of the immunology/transplantation PRN of the American College of … JI Melaragno, LJ Bowman, JM Park, LM Lourenco, CT Doligalski, ... Transplantation 105 (2), 291-299, 2021 | 9 | 2021 |
| Alternatives to immediate release tacrolimus in solid organ transplant recipients: when the gold standard is in short supply MR Jorgenson, JL Descourouez, BL Brady, L Bowman, S Hammad, ... Clinical Transplantation 34 (7), e13903, 2020 | 9 | 2020 |
| Very early cytomegalovirus infection after renal transplantation: a single-center 20-year perspective MR Jorgenson, JL Descourouez, BC Astor, JA Smith, F Aziz, RR Redfield, ... Virology: Research and Treatment 10, 1178122X19840371, 2019 | 9 | 2019 |
| Management of tumor necrosis factor α inhibitor therapy after renal transplantation: a comparative analysis and associated outcomes CS Quinn, MR Jorgenson, JL Descourouez, BL Muth, BC Astor, ... Annals of Pharmacotherapy 53 (3), 268-275, 2019 | 9 | 2019 |
